Allegra Freelander

The Garvan Institute of Medical Research

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Figure S1 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Cristina Guarducci,Agostina Nardone,Douglas Russo,Zsuzsanna Nagy,Capucine Heraud,Albert Grinshpun,Qi Zhang,Allegra Freelander,Mathew Joseph Leventhal,Avery Feit,Gabriella Cohen Feit,Ariel Feiglin,Weihan Liu,Francisco Hermida-Prado,Nikolas Kesten,Wen Ma,Carmine De Angelis,Antonio Morlando,Madison O'Donnell,Sergey Naumenko,Shixia Huang,Quang-Dé Nguyen,Ying Huang,Luca Malorni,Johann S. Bergholz,Jean J. Zhao,Ernest Fraenkel,Elgene Lim,Rachel Schiff,Geoffrey I. Shapiro,Rinath Jeselsohn

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S6 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Data from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Cristina Guarducci,Agostina Nardone,Douglas Russo,Zsuzsanna Nagy,Capucine Heraud,Albert Grinshpun,Qi Zhang,Allegra Freelander,Mathew Joseph Leventhal,Avery Feit,Gabriella Cohen Feit,Ariel Feiglin,Weihan Liu,Francisco Hermida-Prado,Nikolas Kesten,Wen Ma,Carmine De Angelis,Antonio Morlando,Madison O'Donnell,Sergey Naumenko,Shixia Huang,Quang-De Nguyen,Ying Huang,Luca Malorni,Johann S. Bergholz,Jean J. Zhao,Ernest Fraenkel,Elgene Lim,Rachel Schiff,Geoffrey I. Shapiro,Rinath Jeselsohn

CLINICAL CANCER RESEARCHno. 9 (2024): 1889-1905

Cited0Views0WOSBibtex

Supplementary Tables S1-8 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S2 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S8 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S4 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S3 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S5 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

crossref（2024）

Cited0Views0Bibtex

CDK4/6 Inhibitor Resistance in Estrogen Receptor Positive Breast Cancer, a 2023 Perspective

Fiona H Zhou,Teesha Downton,Allegra Freelander,Joshua Hurwitz,C Elizabeth Caldon,Elgene Lim

Frontiers in cell and developmental biology (2023): 1148792-1148792

Cited2Views0WOSBibtex

Author Statistics

#Papers: 17

#Citation: 29

H-Index: 2

G-Index: 5

Sociability: 4

Diversity: 1

Activity: 9

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn